Tagged with Munit

Puerto Rico Despite being a small island in the Caribbean, measuring just 100 by 35 miles, Puerto Rico has long punched above its weight as an industrial powerhouse. Already a leading producer of everything from blockbuster medicines to high-tech medical devices, how has it got to this point and what comes next?…

Switzerland From its origins in early 20th-century Italy to its present-day role as a trusted partner to leading pharmaceutical players, MUNIT Group has carved a unique space at the intersection of engineering and drug development. With micronization at its core, the company combines proprietary technology, scientific expertise, and strategic foresight to…

Puerto Rico Ivan Lugo, co-founder and board member of Puerto Rico’s Life Science Air Cargo Community, offers valuable insights into recent developments within the island’s logistics sector, particularly the formation of the industry organization. He discusses key advancements within the community, including the creation of a comprehensive cargo data platform and the…

Global Chimeric antigen receptor (CAR-T) therapy was first approved by the US FDA back in 2017 amid a great deal of fanfare and high expectations among patients about its potential as a revolutionary, perhaps even decisive, new pillar in the war on cancer. Five years later, however, many are still left…

Global In recent years, the much-discussed concept of “patient centricity” has been top-of-mind across all corners of the pharma industry. This is especially pertinent now that many innovative drug makers are seeking to become much more than just purveyors of pills and expand along the life science continuum, providing positive healthcare…

Pharma Nicolas Bardonnet, general manager of Promega France, reveals how France hosts both their European application laboratory and European training centre, offering a wide range of courses in molecular biology, cell biology, proteomics and genetic identity. Mr Bardonnet talks about the importance that Promega attaches to supporting the surrounding community, giving…

pharma The country president for South Africa & Sub-Saharan Africa at AstraZeneca reveals why AstraZeneca sees Africa as the next frontier within the pharmaceutical industry, how their Research Trust looks to contribute to academic advancement on the continent, with a focus on non-communicable diseases, and how their Healthy Heart Africa program…

Pharma Iain Barton reveals how the acquisition of RTT Medical by IHS in 2013 has allowed Imperial to become the biggest pharma supply chain and general logistics services player on the African continent; why with a two tier integration they can be the single partner of choice in sub-Saharan Africa for a…

Genetic Immunity Genetic Immunity has been founded in 1998. What drove you to set up the company at that time? J.L: To understand the context better, I first need to give a little bit of background on myself. I left for Germany right after I finished university in Hungary, where I was…